Purpose The aim of the current study was to determine the prevalence and clinical
predictors of germline cancer susceptibility mutations in patients with malignant …

Introduction: Asbestos, the most frequent cause of occupational cancer, continues to be
consumed on a massive scale, with millions of people exposed on a daily basis. This review …

Simple Summary Platin-based chemotherapy with pemetrexed has been the backbone of
meaningful treatment in pleural mesothelioma for the last 16 years, alongside vinorelbine …

Abstract BRCA1‐associated protein‐1 (BAP1) expression is commonly lost in several
tumors including malignant pleural mesothelioma (MPM). Presence or absence of …

Background The important diagnostic challenge facing the cytopathologist is whether a
mesothelial proliferation on effusions represents a malignant mesothelioma (MM) or a …

There is irrefutable evidence that germline BRCA1-associated protein 1 gene (BAP1)
mutations contribute to malignant mesothelioma (MM) susceptibility. However, BAP1 …

Objective The aim of this study was to investigate the utility of BRCA1‐associated protein‐1
(BAP 1), glucose transporter (GLUT)‐1 and desmin expression by immunohistochemistry in …

BRCA1-associated protein-1 (BAP1) is an important nuclear-localized deubiquitinating
enzyme. Dysregulation of BAP1 has been reported in many types of cancers. However …

Pleural mesothelioma (PM) is an aggressive malignancy of the pleural lining that typically
arises secondary to asbestos exposure. With the advent of next-generation sequencing …

Malignant pleural mesothelioma is a neoplasm characterized by a very poor prognosis and
medico-legal implications. Diagnosis, prognosis and therapy are often challenging and …